COVID-19 Infection in Multiple Sclerosis Patients Treated with Rituximab Compared to Natalizumab and Healthy Controls: A Real-World Multicenter Study.

Saved in:

Bibliographic Details
Title:	COVID-19 Infection in Multiple Sclerosis Patients Treated with Rituximab Compared to Natalizumab and Healthy Controls: A Real-World Multicenter Study.
Authors:	Mathew, Thomas¹ chakkuthom@hotmail.com, Garg, Surabhi¹, John, Saji K.¹, Kimi, Mal S.¹, Chhakchhuak, Naom Z.¹, Koshy, Sherina¹, Yangdonq, Tenzin¹, George, Molly¹, Bhardwaj, Shagun¹, Reddy, Yerasu M.², Murgod, Uday³, Kamath, Vikram⁴, Shivde, Sonia¹, Badachi, Sagar¹, Huddar, Akshata¹, Sarma, Gosala R. K.¹, Nadig, Raghunandan¹
Source:	Annals of Indian Academy of Neurology. May/Jun2024, Vol. 27 Issue 3, p264-268. 5p.
Database:	Academic Search Ultimate

Description
ISSN:	09722327
DOI:	10.4103/aian.aian_151_24